P1194: A PHASE IB TRIAL OF ITACITINIB COMBINED WITH ALEMTUZUMAB IN PATIENTS WITH T-CELL PROLYMPHOCYTIC LEUKEMIA (T-PLL)

• T. Kadia,
• F. Ravandi,
• G. Borthakur,
• E. Jabbour,
• G. Montalban-Bravo,
• L. Adewale,
• S. Pierce,
• C. Lacke,
• M. Brandt,
• N. Short,
• N. Jain,
• J. Burger,
• A. Ferrajoli,
• W. Wierda,
• H. Kantarjian

Affiliations

T. Kadia

1 MD Anderson Cancer Center, Houston, United States of America

F. Ravandi

1 MD Anderson Cancer Center, Houston, United States of America

G. Borthakur

1 MD Anderson Cancer Center, Houston, United States of America

E. Jabbour

1 MD Anderson Cancer Center, Houston, United States of America

G. Montalban-Bravo

1 MD Anderson Cancer Center, Houston, United States of America

L. Adewale

1 MD Anderson Cancer Center, Houston, United States of America

S. Pierce

1 MD Anderson Cancer Center, Houston, United States of America

C. Lacke

1 MD Anderson Cancer Center, Houston, United States of America

M. Brandt

1 MD Anderson Cancer Center, Houston, United States of America

N. Short

1 MD Anderson Cancer Center, Houston, United States of America

N. Jain

1 MD Anderson Cancer Center, Houston, United States of America

J. Burger

1 MD Anderson Cancer Center, Houston, United States of America

A. Ferrajoli

1 MD Anderson Cancer Center, Houston, United States of America

W. Wierda

1 MD Anderson Cancer Center, Houston, United States of America

H. Kantarjian

1 MD Anderson Cancer Center, Houston, United States of America